Stay updated on Birinapant and Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Birinapant and Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Birinapant and Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    - The page revision now shows v3.6.5, replacing v3.6.4. This indicates a minor maintenance update to the page without altering study content or results.
    Difference
    0.0%
    Check dated 2026-08-11T20:25:57.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    This page update reflects a minor version bump from v3.6.3 to v3.6.4. The change indicates an internal revision and does not modify study details or the user-facing content.
    Difference
    0.0%
    Check dated 2026-07-21T13:13:07.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The site’s revision indicator was updated from v3.6.0 to v3.6.3, reflecting an underlying system update rather than a change to the study data.
    Difference
    0.0%
    Check dated 2026-06-30T02:24:36.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Recruitment has ceased for this study, and new help/join-related sections were added along with a header formatting update for Intervention/Treatment and a revision tag updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T20:20:48.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4. This appears to be a frontend software version update and does not alter the underlying study information.
    Difference
    0.1%
    Check dated 2026-06-08T17:19:45.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.5.3 to v3.5.4, signaling a software/template update for the page. This change reflects a maintenance deployment on the page without altering the trial details.
    Difference
    0.1%
    Check dated 2026-05-18T13:25:22.000Z thumbnail image

Stay in the know with updates to Birinapant and Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Birinapant and Pembrolizumab in Solid Tumors Clinical Trial page.